| Cvs Pharmacy #10892 | |
| 10201 Reisterstown Road, Owings Mills, Maryland 21117 | |
| (410) 581-4922 |
| Name | Cvs Pharmacy #10892 |
|---|---|
| Organization Name | Maryland Cvs Pharmacy Llc. |
| Location | 10201 Reisterstown Road, Owings Mills, Maryland 21117 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 581-4922 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
The Global Fund to Fight AIDS, Tuberculosis and Malaria "is cutting its workforce and tightening its focus on 20 countries hardest hit by AIDS, tuberculosis and malaria," Reuters reports. Gabriel Jaramillo, who took over as general manager of the fund in January, "said in a statement that the fund had completed a reorganization that would rebalance its workforce with 39 percent more people managing grants and 38 percent fewer in support roles," the news service notes.
Today, the Obama Administration is announcing both new regulations to empower consumers to appeal decisions made by their health plans or insurance companies and the availability of resources that will be used to help give consumers more control of their health care decisions. These provisions of the Affordable Care Act will help support and protect consumers and help end some of the worst insurance company abuses.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
› Verified 2 days ago
| NPI Number | 1548761851 |
| Organization Name | MARYLAND CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY # 10892 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 10201 Reisterstown Rd, Owings Mills, MD 21117 |
| Phone Number | 401-765-1500 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
The Global Fund to Fight AIDS, Tuberculosis and Malaria "is cutting its workforce and tightening its focus on 20 countries hardest hit by AIDS, tuberculosis and malaria," Reuters reports. Gabriel Jaramillo, who took over as general manager of the fund in January, "said in a statement that the fund had completed a reorganization that would rebalance its workforce with 39 percent more people managing grants and 38 percent fewer in support roles," the news service notes.
Today, the Obama Administration is announcing both new regulations to empower consumers to appeal decisions made by their health plans or insurance companies and the availability of resources that will be used to help give consumers more control of their health care decisions. These provisions of the Affordable Care Act will help support and protect consumers and help end some of the worst insurance company abuses.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
› Verified 2 days ago
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
The Global Fund to Fight AIDS, Tuberculosis and Malaria "is cutting its workforce and tightening its focus on 20 countries hardest hit by AIDS, tuberculosis and malaria," Reuters reports. Gabriel Jaramillo, who took over as general manager of the fund in January, "said in a statement that the fund had completed a reorganization that would rebalance its workforce with 39 percent more people managing grants and 38 percent fewer in support roles," the news service notes.
Today, the Obama Administration is announcing both new regulations to empower consumers to appeal decisions made by their health plans or insurance companies and the availability of resources that will be used to help give consumers more control of their health care decisions. These provisions of the Affordable Care Act will help support and protect consumers and help end some of the worst insurance company abuses.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.
› Verified 2 days ago
Rite Aid Pharmacy 03871 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9300 Lakeside Blvd, Owings Mills, Maryland 21117 Phone: (410) 363-8066 | |
Cvs Pharmacy #16430 Type: Pharmacy Location: 11200 Reisterstown Rd, Owings Mills, Maryland 21117 Phone: (410) 654-9877 | |
Cvs Pharmacy #10892 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10201 Reisterstown Road, Owings Mills, Maryland 21117 Phone: (410) 581-4922 | |
Wegmans Pharmacy #125 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10100 Reisertown Rd, Owings Mills, Maryland 21117 Phone: (443) 471-2345 | |
Giant Pharmacy #165 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9934 Reisterstown Rd, Owings Mills, Maryland 21117 Phone: (410) 363-2390 |